The first part of a three-part series on HMOs. This two-page review article provides background information on HMO structure, metabolism and function.
By Hayley Kuter, BHSc MRes RD, Medical Science Liaison, Medical & Scientific Affairs, Abbott’s Nutrition Business
The second article in this series focuses on the beneficial effects of HMOs on the microbiome.
By Hayley Kuter, BHSc MRes RD, Medical Science Liaison, Medical & Scientific Affairs, Abbott’s Nutrition Business
This final article explores the potential for biosynthesised HMOs and highlights studies which demonstrate their effects.
By Hayley Kuter, BHSc MRes RD, Medical Science Liaison, Medical & Scientific Affairs, Abbott’s Nutrition Business
A brief overview of HMOs and the latest understanding of how they support the developing gut and immune system.
By Rachael H. Buck, PhD Director, Preclinical Research, Volwiler Research Fellow Abbott Nutrition Research and Development
A visual summary of the composition of breastmilk, with a focus on HMOs, especially 2’-FL, and the latest science behind its inclusion in infant formulas.
By Rachael H. Buck, PhD Director, Preclinical Research, Volwiler Research Fellow Abbott Nutrition Research and Development
A deeper dive into 2’-FL, the most prevalent HMO, and the latest understanding of how it strengthens the developing gut and immune system.
By Rachael H. Buck, PhD Director, Preclinical Research, Volwiler Research Fellow Abbott Nutrition Research and Development
A scientific overview of HMOs, with a focus on 2’-FL and how to apply the science to your clinical practice.
By Rachael H. Buck, PhD Director, Preclinical Research, Volwiler Research Fellow Abbott Nutrition Research and Development
Details of nine clinical studies that evaluated Alimentum, EleCare and 2’-FL, summarising their objectives, methods, results and conclusions.
By Abbott
References
IE-SIMILAC-2100003 February 2021
.svg)
.svg)
